BACKGROUND: The potentially damaging effect of free O 2 radicals to cultured embryos may be reduced by adding scavengers to the culture media or by reducing the incubator O 2 levels. However, lowering the O 2 in the culture environment can be expensive, troublesome and may not be justifiable. The objective of this study was to evaluate the effect of lowered incubator O 2 tension on live birth rates in a predominately Day 5 embryo transfer program. METHODS: Two hundred and thirty first-cycle women undergoing routine IVF or ICSI with ejaculated sperm were randomized in a prospective clinical trial and stratified for patient age and physician. Embryos of patients were randomly assigned for culture in either a 21% O 2 (atmospheric) or 5% O 2 (reduced) environment. Clinical endpoints monitored were rates of implantation, clinical pregnancy, live birth and blastocyst cryopreservation. RESULTS: Embryos cultured in a 5% O 2 environment consistently resulted in higher rates of live birth implantation (106/247, 42.9% versus 82/267, 30.7%; difference of 12.2% with 95% confidence interval (CI) of 3.9-20.3, P 5 0.005) and live births (66/115, 57.4% versus 49/115, 42.6%; difference of 14.8% with 95% CI of 1.9-27.0, P 5 0.043) when compared with rates among women whose embryos were cultured in an atmospheric O 2 environment. CONCLUSIONS: The overall increase in live births demonstrated by this study indicates that the effort and expense to culture embryos in a low-O 2 environment is justified. The study was registered at clinicaltrials.gov. NCT00708487.
Introduction
The embryos of various mammalian species, including the human, are not exposed to O 2 concentrations in excess of 8% in vivo (Yedwab et al., 1976; Bayatt-Smith et al., 1991; Fisher and Bavister, 1993) . Not unexpectedly, numerous studies in animals have consistently demonstrated that embryo culture in low-O 2 concentrations markedly improves in vitro embryo development and subsequent pregnancy outcomes when compared with similar culture in atmospheric O 2 concentrations (Harlow and Quinn, 1979; Batt et al., 1991; Yuan et al., 2003; Karja et al., 2004; Leoni et al., 2007) . However, when culturing human embryos in lower O 2 concentrations, the expected improvement in measured laboratory parameters (Dumoulin et al., 1995 (Dumoulin et al., , 1999 or clinical outcomes (Kea et al., 2007) were not observed. One would expect to see beneficial effects on embryo development and improved clinical outcomes when culturing embryos in a lowered O 2 tension, regardless of the species.
This discrepancy between animal and human data may be partially explained by species differences in embryo physiology, characteristics of specific laboratory animal strains or a variety of culture conditions (Bavister, 2004) . Furthermore, only rare opportunities exist to collect relevant human data within a prospective, randomized experimental design with an adequate number of patients. Common confounding factors observed in past human studies include patient demographics (Kea et al., 2007) , physician effect, incubator effect and observational time period (Catt and Henman, 2000) . Published investigations related to this subject often do not include meaningful clinical endpoints such as live births, but rather are limited to less important parameters such as implantations (Noda et al., 1994; Kea et al., 2007) . Animal data suggest that embryo morphology or even initial implantations, after culturing in different atmospheric conditions, are not accurate predictors of ultimate clinical outcomes. True embryo competency should be confirmed by a live birth (Karagenc et al., 2004; Waldenström et al., 2008) .
The human studies which found no benefit in early clinical outcomes with a lowered O 2 tension in the incubators were all associated with embryo transfers on Day 2 or on Day 3 (Dumoulin et al., 1999) . This is in contrast to animal studies in which blastocyst transfer was the routine (Umaoka et al., 1991; Karagenc et al., 2004) . One could argue, therefore, that the human embryo may not be as sensitive to O 2 toxicity during the oviductal stages (Houghton et al., 1996; Bavister, 2004) . Since it is suggested that it is the inner cell mass (ICM) of the blastocyst that is preferentially damaged when cultured in supraphysiological O 2 concentrations (Van Soom et al., 2002; Bavister, 2004) , early Day 2 or Day 3 transfer may preclude O 2 damage of human IVF embryos. This argument might be used to justify the culture of embryos in a reduced O 2 environment only after Day 3 of culture. However, animal studies indicate that after in vitro maturation at different O 2 concentrations, mouse embryo and fetal development are negatively affected when oocytes are matured in 21% O 2 (Banwell et al., 2007) . In addition, the developmental potential of blastocysts can be severely impaired following fertilization in 21% O 2 (Leoni et al., 2007) or after a single hour of atmospheric O 2 exposure at the 1-cell stage (Pabon et al., 1989 ). It appears that the effects of O 2 damage may already be present in the very early animal embryo, but only be manifested at the blastocyst stage or later in the form of compromised clinical outcomes.
The damaging effects that accrue in animal embryos cultured at atmospheric O 2 concentrations have been attributed to the generation of reactive oxygen species that can cause organelle and membrane damage (Fujitani et al., 1997; Kwon et al., 1999) , direct and indirect DNA damage (Iwata et al., 2000) and altered gene expression (Harvey et al., 2004) . These negative effects may potentially be reduced by adding free radical scavengers (Umaoka et al., 1992; Orsi and Leese, 2001) and antioxidants (Umaoka et al., 1991) to the culture media or by reducing the incubator O 2 tension (Dumoulin et al., 1999) . In the absence of proven clinical benefits of lowered incubator O 2 tension in the human, some have chosen to add antioxidants to the embryo culture media (Umaoka et al., 1991 (Umaoka et al., , 1992 Catt and Henman, 2000) . If the damaging effects of supraphysiological O 2 concentrations on human embryos were reliably and innocuously subverted by the addition of antioxidants, it may be a less expensive and less labor-intensive alternative. Intuitively, it seems more rational to prevent the formation of damaging agents in and around growing embryos in the first place by culturing embryos in reduced O 2 concentrations, rather than to attempt neutralization of these agents after their formation (Catt and Henman, 2000) . Relying only on free radical scavengers and antioxidants to protect embryos in a supraphysiological O 2 culture environment also assumes that these protective substances can reach their target molecules inside the embryonic cells before damage ensues. Furthermore, there are mechanisms by which O 2 may cause damage to embryos such as altered gene expression that may not be prevented by the simple addition of antioxidants to the culture media (Harvey et al., 2004) .
Because the culture of human embryos in a reduced O 2 environment appears to be the most physiological alternative and the overwhelming evidence that supports such a thesis in many other mammalian species, a study was designed to test the effect of a lowered O 2 embryo culture environment in a private, predominantly Day 5 transfer, human IVF program. The study design attempted to minimize common confounding factors and to measure live births as the ultimate clinical outcome.
Materials and Methods

Study design
Only first-cycle patients undergoing routine IVF or ICSI with ejaculated sperm were recruited for this study over a 1-year period following local Institutional Review Board approval. Thus, the number of cycles was equal to the number of patients enrolled. A total of 230 patients were randomly assigned to one of two treatment groups and prospectively stratified for physician, patient age (34, 35-37, 38-40, .40 years) and source of oocytes (homologous, donor) to exclude any possible effect of physician or patient age on the results (Tables I and II , Fig. 1 ). Gametes and embryos were cultured at 37.18C either in an atmosphere of 5% CO 2 in air (21% O 2 ) (high-O 2 treatment group, n ¼ 115) or in 5% CO 2 , 5% O 2 , 90% N 2 (low-O 2 treatment group, n ¼ 115). Patients were randomly assigned to a treatment group within physician and patient age group (donor oocytes when applicable) 2 days before the oocyte retrieval so that the complete treatment cycle could be performed in the pre-assigned atmospheric conditions to include setting up of all retrieval and culture dishes. Exclusion criteria were as follows: one or more previous IVF cycles without a live birth, the need to use non-ejaculated sperm (epididymal or testicular), no oocytes retrieved or no fertilization, PGD or cryobanking of all embryos for any reason.
Culture conditions
All media, oil and prepared micro-droplet culture dishes were equilibrated overnight in their respective atmospheric conditions. Oocytes were retrieved and washed in P-1 medium (Irvine Scientific, Santa Ana, CA, USA) supplemented with 3 g/l of human serum albumin (HSA, 0.3% weight/volume) using an isolette (37.18C, 5% CO 2 in air). The washed oocytes were then placed in 750 ml of HSA-supplemented P-1 medium under oil and incubated at 37.18C in their respective gas phase for 6 h before insemination or ICSI. In vitro insemination took place in 200 ml droplets of equilibrated, HSA-supplemented P-1 medium under oil. Oocytes that were sperm-injected were cultured overnight in 40 ml microdroplets of equilibrated HSA-supplemented G-1 medium (Vitrolife, Götheburg, Sweden) under oil. After 15-19 h of insemination or ICSI, all normally [2 pronuclei (PN)] fertilized oocytes were washed and transferred to fresh 40 ml microdroplets of equilibrated, HSA-supplemented G-1 medium under oil and returned to their designated incubator. On Day 3, embryos were evaluated, washed and transferred to 40 ml microdroplets of equilibrated, HSA-supplemented G-2 medium (Vitrolife) for transfer to the patient or for further culture to the blastocyst stage. All embryos were again transferred to fresh 40 ml microdroplets of equilibrated, HSA-supplemented G-2 medium on Day 5.
Embryo transfer and cryopreservation
Embryos were transferred to patients on Day 2-3 or on Day 5, depending on the number and quality of embryos available for transfer. Should either the low-O 2 or high-O 2 treatment have significantly disadvantaged the embryos early on, one would expect more Day 2-3 transfers in the affected treatment group due to more patients with poor morphology embryos on those days. Embryos were transferred on Day 2 -3 only if the physician and patient were comfortable transferring all embryos that reached an acceptable developmental stage (e.g. three 6-8-cell embryos on Day 3 in a 40-year old patient). Day 2-3 transfers were typically performed when the patients were older, when a limited number of oocytes had been retrieved, there were low numbers of fertilized oocytes or when there was a poor prognosis based on the Day 2/Day 3 embryo morphology. Transferring the embryos of these patients on Day 2-3, rather than forcing 5 days of culture is the standard clinical approach in our program. This approach has been very successful in reducing the likelihood that there will be no viable embryo(s) to transfer on Day 5. In contrast, good prognosis patients were encouraged to transfer a single blastocyst to reduce the probability of twins.
Should the patient and physician not feel comfortable with the transfer of all sufficiently advanced embryos (e.g. 2 or 3 perfect 8-cell embryos in a 30-year old patient), the embryo transfer procedure was delayed until Day 5. On Day 5, one or two blastocysts were chosen for transfer and supernumerary blastocysts were cryopreserved. Blastocysts were frozen after IVF or ICSI if they met the standard criteria for cryopreservation in this program. A blastocyst had to be fully expanded (.150 mm in diameter) with an ICM grade of A, B or C (A being the best, F being the worst) and a trophoblast grade of A or B (A being the best, D being the worst). Cryopreservation took place on Day 5 and/or Day 6 and did not occur before 112 or after 140 h post-insemination.
Incubators
Two identical Forma model 3120 incubators were dedicated to this study which differed only in the preset O 2 concentrations (5 and 21%) to rule out subtle differences between different models or brands of incubators such as incubator recovery time, internal incubator temperature gradients or any other incubator-related confounding factor. The embryos of a maximum of three patients were incubated at any one time in one incubator to optimize temperature and gasphase recovery times after opening. Incubator CO 2 and O 2 concentrations were confirmed on a daily basis throughout this study period, using a manual CO 2 and O 2 fyrite gas analyzer with a measuring range of 0-7.6% (Bacharach, New Kensington, PA, USA). In addition, the partial pressures of CO 2 (normal arterial range 32-40 mm Hg) and O 2 (normal arterial range 83 -108 mm Hg) were measured using a calibrated blood-gas analysis machine. The partial pressures of CO 2 and O 2 were confirmed to be within these normal human arterial blood-gas ranges for each new batch of medium (approximately once per month) for each incubator dedicated to this study. Similarly, the pH equivalence (study normal of 7.30-7.40) for each batch of medium in each study-dedicated incubator was confirmed during the same blood-gas analysis procedure, regardless of the O 2 concentration.
Statistical analyses
Laboratory and clinical endpoints included fertilization rate, cleavage rate, number of embryos per transfer, frequency of cryopreservation, implantation rate, live-birth implantation rate, clinical pregnancy rate, live birth rate, singleton and twin birth weights. The two primary endpoints targeted in this study were live-birth implantation rate and live birth rate. All other endpoints were considered to be secondary. The anticipated sample size to detect a minimum difference of 10% in live birth rate with a power of 80% and an a-error level of 5% was determined to be 150 patients in each treatment group (300 patients in total). The live birth rate expected for this population of patients in our program at the commencement of this study was 45%. Therefore, the power calculation was based on a 10% increase in live birth rate from 45 to 55%. Differences in implantation rates could be detected earlier (more statistical power with more embryos transferred than patients enrolled). For this reason, analyses of implantations were performed continually throughout this study to detect a possible treatment effect earlier and to ensure ongoing feasibility. Normal fertilization rate was calculated by the number of 2 PN embryos obtained by IVF and ICSI divided by the number of mature oocytes retrieved. Cleavage rate was the percentage of 2 PN embryos that divided into two or more cells on Day 2 of embryo culture. The implantation rate is defined as the number of intrauterine sacs observed by ultrasound within 8 weeks of embryo transfer divided by the number of embryos transferred. The live-birth implantation rate is the number of babies born alive divided by the number of embryos transferred. The clinical pregnancy rate was calculated as the number of patients with at least one intrauterine sac observed by ultrasound within 8 weeks of embryo transfer divided by the number of patients with an oocyte retrieval. The live birth rate is the number of patients with one or more live-born infants divided by the number of patients with an oocyte retrieval. Multi-variate analyses were performed to evaluate the overall treatment effect on clinical success rates, while controlling for the effects of covariates. Specifically, a logistical regression (LR) analysis was used to test for the effect of O 2 concentration on live births, while controlling for covariates.
Specific covariates considered included the age group of the patient, day of transfer and the number of embryos per transfer. Furthermore, the primary and secondary endpoints were analyzed with general linear models for proportions, controlling for the same covariates. Differences in frequencies of fertilization, cleavage, and cryopreservation were evaluated with Pearson's x 2 test with Yates' continuity correction as independent variables (P , 0.05). A two-tailed t-test was used to test for differences in singleton and twin birth weights.
Results
The results of the LR showed that the model was highly significant (LR , 0.001) while rejecting the null hypothesis of no effect. The O 2 treatment (P ¼ 0.032), age group (P ¼ 0.042) and day of transfer (P ¼ 0.004) were all significant predictors. The number of embryos per transfer was not a significant predictor (P ¼ 0.198). When culturing embryos in 5% O 2 , the odds of a resulting live birth was 1.85 times higher [95% confidence interval (CI): 1.06-3.23] than when culturing in 21% O 2 . No differences were found between the low-O 2 and high-O 2 treatment groups in normal fertilization rate (1129/1491, The results for the general linear models for proportions, controlling for day of transfer, patient age and the number of embryos per transfer are presented in Tables I-V. The low-O 2 treatment group appeared to consistently result in improved clinical outcomes for all age groups tested (Tables I and II) . A significant improvement in the implantation rate was specifically observed in the 34-year-old age group (62/138, 44.9% versus 72/125, 57.6%; difference of 12.7% with 95% CI: 0.6-24.2, P ¼ 0.039) as well as an increase in the live-birth implantation rate for the 38-40-year-old age group (3/47, 6.4% versus 13/ 37, 35.1%; difference of 28.8% with 95% CI: 11.6-45.4, P ¼ 0.01) ( Table I ). The lack of significance in the other age groups or in all parameters within a specific age group were due, in part, to the lower numbers of patients represented in these subgroups. However, the overall results from this study across all patient age groups showed a significant improvement in the implantation rate, live-birth implantation rate, clinical pregnancies as well as live births when culturing gametes and embryos in 5% O 2 (Tables I, II and V) . For example, the overall live birth rate increased from 49/115 (42.6%) to 66/ 115 (57.4%) which differed by 14.8% (95% CI, 1.9-27.0) ( Table V) . The number of patients needed with embryos to be cultured at a 5% O 2 concentration to gain one additional live birth was 6.8 (number needed to treat: 1/0.148, 95% CI 3.5-50).
When transferring embryos on Day 2-3, neither the implantation rate nor the live-birth implantation rate differed between the two treatment groups (Table III) . Similarly, neither the clinical pregnancy rate nor the live birth rate was different when comparing the low-O 2 and high-O 2 treatment group if the embryos were transferred on Day 2 -3 (Table III ). In contrast, the implantation rate, the live-birth implantation rate and the clinical pregnancy rate were significantly improved in patients with embryos from the low-O 2 treatment group when transferring blastocysts on Day 5 (Table IV) . The birth weights of babies born from embryos cultured in the low-O 2 treatment group were not different from those of babies born from the high-O 2 treatment group when comparing singleton (n ¼ 26, 3361 + 685 g and n ¼ 19, 3555 + 339 g, mean + SD; respectively) and twin births (n ¼ 80, 2384 + 405 g and n ¼ 54, 2271 + 709 g, mean + SD; respectively). No triplets were born in the low-O 2 treatment group and three sets of triplets were born in the high-O 2 treatment group.
Discussion
Results from this study clearly demonstrate the beneficial effect of culturing human embryos in a lowered O 2 concentration and confirm the findings of numerous animal studies reporting the same. With a difference of 14.8% in the live birth rate between the low-O 2 and high-O 2 treatment groups, the embryos of only 7 patients have to be cultured in a reduced O 2 culture environment to result in one additional live birth or, alternatively, the low-O 2 treatment group, involving 115 patients in this study, gained 17 additional live births.
These results contrast with those of previous studies in the human that found either no benefit of culturing human embryos at lower O 2 concentrations (Dumoulin et al., 1995) or some improvement in laboratory parameters only, without significantly affecting clinical outcomes (Noda et al., 1994; Dumoulin et al., 1999) . It was reported that the implantation rate was increased from 10 to 14% and the pregnancy rate from 19 to 32% when culturing human embryos in MINC (Cook IVF) incubators in an atmosphere of 6% CO 2, 5% O 2 and 89% N 2 instead of in standard water-jacketed incubators in an atmosphere of 5% CO 2 in air (Catt and Henman, 2000) . We know that the incubator type can have a profound effect on temperature and gas-phase recovery dynamics with significant effects on human blastocyst quality (Fujiwara et al., 2007) . These results reported by Catt and Henman appear to be seriously confounded by the difference in incubator type and CO 2 concentration between the two treatment groups. Other potentially confounding variables in their study include the non-simultaneous time period of treatment application, physician effect and various patient factors. The improvements in reported clinical outcomes may not have been due to the different O 2 concentrations at all. The controlled circumstances in which the present study was conducted is likely to have been crucial in differentiating the effect of incubator O 2 concentration from the many typical confounding factors found in other similar studies in the human.
Embryo transfers in most human studies have been conducted on Day 3, not allowing for the lowered O 2 concentration to benefit blastocyst and ICM development in vitro following embryonic genome activation (Dumoulin et al., 1995 (Dumoulin et al., , 1999 Catt and Henman, 2000) . Interestingly, implantations and clinical pregnancies were almost identical in our study as well, regardless of the O 2 concentration when considering Day 2-3 transfers only. When blastocyst transfers were evaluated in a small study of 22 patients, the clinical pregnancy rate appeared to have improved in a reduced O 2 environment, although the number of patients was too small to reach statistical significance (Kea et al., 2007) . A recent study, comparing low-O 2 and atmospheric-O 2 culture of blastocysts, yielded a better numerical blastocyst outcome and a 10% improvement in relative birth rate, following culture in a reduced oxygen environment (Waldenström et al., 2008) . The overall improvement in implantations and clinical pregnancies observed when embryos were cultured in a reduced O 2 environment in our study, were also exclusively due to the marked improvements seen following blastocyst transfers. Roughly, 76% of all transfers in this study were conducted on Day 5. The transfer of some embryos on Day 2-3 in this study may complicate the analyses and the interpretation of the results. However, the lack of any benefit seen when culturing in low-O 2 concentrations and transferring embryos on Day 2-3 in this study, compared with the significant improvements seen when transferring on Day 5, may partially explain why the beneficial effect of low-O 2 culture was not identified in earlier human studies in which transfers occurred on Day 2-3.
The higher number of embryos per transfer for patients in the high-O 2 treatment group were probably due to the relatively higher number of Day 2 -3 transfers in this group (29 versus 19%) . Typically, three embryos were transferred on Day 2 -3, but only one or two embryos on Day 5, resulting in this higher average number of embryos per transfer observed for the high-O 2 treatment group. Based on the criteria for transferring embryos on Day 2 -3 in this study, it can be assumed that the more frequent observation of lower numbers of appropriately advanced embryos on Day 2 -3 by the embryologists resulted in this bias towards Day 2 -3 embryo transfers in the high-O 2 treatment group.
Most studies evaluating the influence of incubator O 2 concentration in the human have focused on laboratory endpoints and some may include clinical pregnancies as the ultimate endpoint (Kea et al., 2007) . As demonstrated in various animal models, laboratory outcomes and even initial clinical outcomes may not accurately reflect the ability of embryos to result in live offspring (Karagenc et al., 2004) . We also found no change in fertilization rate or cleavage rate when culturing embryos in a reduced O 2 environment. Initial clinical outcomes (implantation rate and clinical pregnancy rate) were only affected by atmospheric O 2 concentrations when considering Day 5 transfers. It can be argued, therefore, that only the embryos of blastocysttransfer patients should be cultured in 5% O 2 and that the change to the reduced O 2 environment could be delayed until the third day of culture. However, numerous animal studies have found that even a brief exposure of pronuclear or cleavagestage embryos to atmospheric O 2 can be detrimental even though it may only be manifested at the morula or blastocyst stage (Pabon et al., 1989; Karagenc et al., 2004) . When considering not only the initial clinical results in the present study but also the eventual live birth implantations and live births, it became apparent that even embryos transferred on Day 2-3 might have benefited from culture in reduced O 2 as more implantations were lost from the high-O 2 treatment group. Therefore, selective later-stage reduced O 2 culture may be an ill-advised approach since the damaging effects of atmospheric O 2 may already be present in early embryos but only manifested at later stages of development and expressed as altered metabolism or gene expression with reduced viability.
Indications were that more patients had some blastocysts to cryopreserve and that more blastocysts were frozen per patient when culture took place in a reduced O 2 environment. However, with only a fraction of patients typically having embryos to cryopreserve, the number of patients enrolled in this study was not sufficient to achieve statistical significance for differences in cryopreservation rates between the two treatment groups. Future studies should consider not only the number of embryos cryopreserved following culture in reduced O 2 concentrations, but also the viability of the frozen -thawed blastocysts following their transfer to the uterus. No detrimental increase in birth weight when culturing in atmospheric O 2 concentrations could be demonstrated in this study as previously reported in calves (Iwata et al., 2000) .
It has been reported that porcine embryos obtained from different sources (in vitro, in vivo or parthenogenic) differ in resilience when exposed to atmospheric O 2 concentrations (Booth et al., 2005) . One may, therefore, speculate that the more robust embryos from younger patients or embryos derived from donor oocytes may not require the lowered O 2 tension. However, the consistent pattern of increased live births across all age groups in this study when culturing in a low-O 2 environment suggests that the embryos of all patients may benefit from a reduced O 2 environment. The overall increase in live births when culturing embryos in a reduced O 2 environment in this study, clearly justifies the additional effort and expense associated with low-O 2 culture. Even though extended culture of embryos to Day 5 may be responsible, in part, for the demonstration of the pronounced beneficial effect of lower O 2 concentrations on live births, human embryos should be cultured in a low-O 2 environment through all in vitro stages of development to ensure the highest live birth rate and most appropriate gene expression.
